SEC Tracker
Get the app

Cartesian Therapeutics RNAC

Michael Singer - Insider ownership filing (4)

Michael Singer, insider filing for RNAC

Form
4
Filed
Importance
Routine
  1. Insider ownership filing (4)
  2. Reports beneficial ownership changes

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Cartesian Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Galectin Therapeutics GALT public float $109M, Jun 30, 2025
  2. Atossa Therapeutics ATOS public float $107M, Jun 30, 2025
  3. Enanta Pharmaceuticals ENTA public float $111M, Mar 31, 2025, over 18 months old
  4. TuHURA Biosciences HURA public float $111M, Jun 30, 2025
  5. Fennec Pharmaceuticals FENC public float $106M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.